The DOI matches its Crossref record; 258 of the 261 references it cites were found in a registry or an index.
Extrapulmonary manifestations of COVID-19
Open accessAbstract
Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and arrhythmia, acute coronary syndromes, acute kidney injury, gastrointestinal symptoms, hepatocellular injury, hyperglycemia and ketosis, neurologic illnesses, ocular symptoms, and dermatologic complications. Given that ACE2, the entry receptor for the causative coronavirus SARS-CoV-2, is expressed in multiple extrapulmonary tissues, direct viral tissue damage is a plausible mechanism of injury. In addition, endothelial damage and thromboinflammation, dysregulation of immune responses, and maladaptation of ACE2-related pathways might all contribute to these extrapulmonary manifestations of COVID-19. Here we review the extrapulmonary organ-specific pathophysiology, presentations and management considerations for patients with COVID-19 to aid clinicians and scientists in recognizing and monitoring the spectrum of manifestations, and in developing research priorities and therapeutic strategies for all organ systems involved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the virus facilitates the release of coagulation factors, the secretion of inflammatory cytokines, and the formation of leukocyte-platelet aggregates, which might be important mechanisms leading to thromboembolic complications observed in severe COVID-19 (Ackermann et al., 2020; Gupta et al., 2020; Zhang et al., 2020b).”
From COVID-19 and the human innate immune system (2021) · cites this paper as Gupta et al., 2020
Experimental — accuracy not yet measuredIn the citing paper
“Disease courses range from mainly asymptomatic and mild courses to more severe and critical courses in 10%–20% of symptomatic patients who are at considerable risk of fatality with many different organ systems involved in differing combinations and with variable symptoms (Gupta et al., 2020)”
From COVID-19 and the human innate immune system (2021) · cites this paper as Gupta et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Martínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,292
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Research works printed but not linked: 1
- Pilotto, A. et al. Steroid-responsive encephalitis in Covid-19 disease. Ann. Neurol. (2020). · DOI
Cited by
Sorted by citations
Items 701–800 of 1,002
Freund, O., Eviatar, T., & Bornstein, G. (2022) · Rheumatology International · doi:10.1007/s00296-022-05106-3 · Cited by 26
Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2
Lai, Y., Cheng, Y., Chao, C.-H., Chang, Y., Chen, C.-D., Tsai, W., Wang, S., Lin, Y., Chang, C., Chuang, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868724 · Cited by 26
Consolaro, E., Suter, F., Rubis, N., Pedroni, S., Moroni, C., Pastò, E., Paganini, M. V., Pravettoni, G., Cantarelli, U., Perico, N., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.785785 · Cited by 26
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
Wettstein, L., Knaff, P. M., Kersten, C., Müller, P., Weil, T., Conzelmann, C., Müller, J. A., Brückner, M., Hoffmann, M., Pöhlmann, S., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03613-4 · Cited by 26
Vega, M. D., Olivera, D., Davanzo, G. G., Bertullo, M., Noya, V., de Souza, G. F., Muraro, S. P., de Castro, Í. M. S., Arévalo, A. P., Crispo, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn6545 · Cited by 26
Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature
Pezzaioli, L. C., Gatta, E., Bambini, F., Facondo, P., Gava, M., Cavadini, M., Buoso, C., Lodovico, E. D., Rotondi, M., Ferlin, A., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1027047 · Cited by 26
Low molecular weight cytotoxic components (DAMPs) form the post-COVID-19 syndrome
Klimova, E. M., Божков, А. И., Lavinska, O. V., Drozdova, L. A., & Kurhuzova, N. I. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152316 · Cited by 26
Venous thromboembolism in viral diseases: A comprehensive literature review
Zerangian, N., Erabi, G., Poudineh, M., Monajjem, K., Diyanati, M., Khanlari, M., Khalaji, A., Allafi, D., Faridzadeh, A., Amali, A., et al. (2023) · Health Science Reports · doi:10.1002/hsr2.1085 · Cited by 26
Dejani, N. N., Elshabrawy, H. A., Filho, C. D. S. M. B., & de Sousa, D. P. (2021) · Biomolecules · doi:10.3390/biom11081254 · Cited by 26
Probiotics and Coronavirus disease 2019: think about the link
Angurana, S. K., & Bansal, A. (2020) · British Journal Of Nutrition · doi:10.1017/s000711452000361x · Cited by 25
Ahmed, A. R., Ebad, C. A., Stoneman, S., Satti, M. M., & Conlon, P. J. (2020) · World Journal of Nephrology · doi:10.5527/wjn.v9.i2.18 · Cited by 25
Rieder, M., Wirth, L., Pollmeier, L., Jeserich, M., Goller, I., Baldus, N., Schmid, B., Busch, H.-J., Hofmann, M., Thimme, R., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa741 · Cited by 25
Hypertension and Electrolyte Disorders in Patients with COVID-19
Lim, J., Jung, H., Choi, J., Park, S.-H., Kim, C., Kim, Y.-L., & Cho, J. (2020) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2020.18.2.23 · Cited by 25
COVID-19-Associated Neurological Manifestations: An Emerging Electroencephalographic Literature
Vellieux, G., Sonneville, R., Vledouts, S., Jaquet, P., Rouvel-Tallec, A., & d’Ortho, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.622466 · Cited by 25
Verhoef, P. A., Kannan, S., Sturgill, J., Tucker, E. W., Morris, P. E., Miller, A. C., Sexton, T. R., Koyner, J. L., Hejal, R. B., Brakenridge, S. C., et al. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000374 · Cited by 25
COVID-19 and comorbidities of hepatic diseases in a global perspective
Ahmad, A., Ishtiaq, S. M., Khan, J. A., Aslam, R., Ali, S., & Arshad, M. I. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i13.1296 · Cited by 25
Echocardiographic assessment of the right ventricle in COVID-19: a systematic review
Ghidini, S., Gasperetti, A., Winterton, D., Vicenzi, M., Busana, M., Pedrazzini, G. B., Biasco, L., & Tersalvi, G. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02353-6 · Cited by 25
Expression of SARS-CoV-2 receptor “ACE2” in human pancreatic β cells: to be or not to be!
El‐Huneidi, W., Hamad, M. A., & Taneera, J. (2021) · Islets · doi:10.1080/19382014.2021.1954458 · Cited by 25
Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms
Aksoyalp, Z. Ş., & Samur, D. N. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174548 · Cited by 25
Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19
Lu, R., Ko, S.-H., Wy, C., Chang, Y., Lin, H.-T., & Wu, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212412 · Cited by 25
Endothelial Dysfunction in SARS-CoV-2 Infection
Nappi, F., & Singh, S. (2022) · Biomedicines · doi:10.3390/biomedicines10030654 · Cited by 26
Clinical and subclinical acute kidney injury in children with mild-to-moderate COVID-19
Saygılı, S., Canpolat, N., Çiçek, R. Y., Ağbaş, A., Yılmaz, E. K., Kılınç, A. A., Aygün, D., Akkoç, G., Demirbaş, K. C., Konukoğlu, D., et al. (2022) · Pediatric Research · doi:10.1038/s41390-022-02124-6 · Cited by 26
Correlation between Type I Interferon Associated Factors and COVID-19 Severity
Bencze, D., Fekete, T., & Pázmándi, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810968 · Cited by 25
Ocular manifestations of recent viral pandemics: A literature review
Taha, M. J. J., Abuawwad, M. T., Alrubasy, W. A., Sameer, S. K., Alsafi, T., Al-Bustanji, Y., Abu‐Ismail, L., & Nashwan, A. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1011335 · Cited by 25
Ferrara, M. C., Zarcone, C., Tassistro, E., Rebora, P., Rossi, E., Luppi, F., Foti, G., Squillace, N., Lettino, M., Strepparava, M. G., et al. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02308-4 · Cited by 25
Kidney outcome after mild to moderate COVID-19
Schmidt‐Lauber, C., Hänzelmann, S., Schunk, S. J., Petersen, E. L., Alabdo, A., Lindenmeyer, M. T., Hausmann, F., Kuta, P., Renné, T., Twerenbold, R., et al. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad008 · Cited by 25
Diagnostic delays among COVID‐19 patients with a second concurrent diagnosis
Freund, O., Azolai, L., Sror, N., Zeeman, I., Kozlovsky, T., Greenberg, S. A., Weiss, T. E., Bornstein, G., Tchebiner, J. Z., & Frydman, S. (2023) · Journal of Hospital Medicine · doi:10.1002/jhm.13063 · Cited by 25
COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations
Shu, H., Zheng, W., Li, N., Zhang, Z., Ceesay, B. M., Peng, Y., Zhou, N., & Wang, D. W. (2023) · Aging and Disease · doi:10.14336/ad.2023.0314 · Cited by 25
Direct and indirect impact of SARS-CoV-2 on the brain
Peron, J. P. S. (2023) · Human Genetics · doi:10.1007/s00439-023-02549-x · Cited by 25
Zhu, H., Byrnes, C., Lee, Y. T., Tuymetova, G., Duffy, H. B. D., Bakir, J. Y., Pettit, S. N., Angina, J., Springer, D., Allende, M. L., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202300149r · Cited by 25
Mermiri, M., Mavrovounis, G., Laou, E., Papagiannakis, N., Pantazopoulos, I. N., & Chalkias, A. F. (2023) · Anesthesiology and Perioperative Science · doi:10.1007/s44254-023-00013-7 · Cited by 25
Moderate COVID‐19 Disease Is Associated With Reduced Bone Turnover
Kerschan‐Schindl, K., Dovjak, P., Butylina, M., Rainer, A., Mayr, B., Röggla, V., Haslacher, H., Weber, M., Jordakieva, G., & Pietschmann, P. (2023) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4822 · Cited by 25
Gonzalez‐Garcia, P., Moreno, O. F., Peñata, E. Z., Calderón-Villalba, A., Pacheco-Lugo, L., Acosta-Hoyos, A. J., Camacho, J. L. V., Quiroz, R. N., Pacheco‐Londoño, L. C., Aroca, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098290 · Cited by 25
Alam, M. S., Hasan, M. N., Maowa, Z., Khatun, F., Nazir, K. H. M. N. H., & Alam, M. Z. (2023) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2023.j665 · Cited by 25
Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis
Booysen, P., Wilkinson, K. A., Sheerin, D., Waters, R., Coussens, A. K., & Wilkinson, R. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1254206 · Cited by 25
Subramaniam, S., Ogoti, Y., Hernández, I., Zogg, M., Botros, F., Burns, R. T., DeRousse, J. T., Dockendorff, C., Mackman, N., Antoniak, S., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004360 · Cited by 25
The role of lovastatin in the attenuation of COVID-19
Karampoor, S., Hesamizadeh, K., Shams, Z., Novin, A. G., Farahmand, M., Zahednasab, H., Mirzaei, R., Zamani, F., Hajibaba, M., Bouzari, B., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108192 · Cited by 25
Cheung, M. D., Erman, E. N., Liu, S., Erdmann, N. B., Ghajar-Rahimi, G., Moore, K. H., Edberg, J. C., George, J. F., & Agarwal, A. (2021) · Kidney360 · doi:10.34067/kid.0005522021 · Cited by 25
Bhadelia, N., Belkina, A. C., Olson, A., Winters, T., Urick, P., Lin, N., Rifkin, I. R., Kataria, Y., Yuen, R. R., Sagar, M., et al. (2021) · medRxiv · doi:10.1101/2021.01.21.21249176 · Cited by 25
Dai, Y.-J., Zhang, W.-N., Wang, W.-D., He, S.-Y., Liang, C.-C., & Wang, D.-W. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.51234 · Cited by 24
Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange
Faqihi, F. A., Alharthy, A. M., Memish, Z. A., Kutsogiannis, D. J., Brindley, P. G., & Karakitsos, D. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3397 · Cited by 24
Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19
Mitsuyama, K., Tsuruta, K., Takedatsu, H., Yoshioka, S., Morita, M., Niwa, M., & Matsumoto, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113630 · Cited by 24
New‐onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID‐19)
Ergün, B., Ergan, B., Sözmen, M. K., Küçük, M., Yakar, M. N., Cömert, B., Gökmen, A. N., & Yaka, E. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12619 · Cited by 24
Bilateral adrenal hemorrhage in a man with severe COVID-19 pneumonia
Elkhouly, M. M. N., Elazzab, A. A., & Moghul, S. (2021) · Radiology Case Reports · doi:10.1016/j.radcr.2021.03.032 · Cited by 24
THE CORRELATION BETWEEN PSYCHIATRIC DISORDERS AND COVID-19: A NARRATIVE REVIEW
He, Y., Yu, R., & Ren, J. (2021) · Psychiatria Danubina · doi:10.24869/psyd.2021.76 · Cited by 24
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
Kanimozhi, G., Bharathiraja, P., Pawar, C. S., Khan, H. A., Alrokayan, S., & Prasad, N. R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638334 · Cited by 24
Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience
Podzolkov, V. I., Bragina, A. E., Tarzimanova, A. I., Васильева, Л. В., Batrakova, E. P., Lobova, N. V., Bykova, E. E., & Khachuroeva, M. M. (2021) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2021-04-08 · Cited by 24
Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction
Kaundal, R. K., Kalvala, A. K., & Kumar, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02412-y · Cited by 24
Wu, H., Liao, S., Wang, Y., Guo, M. S., Lin, X., Wu, J., Wang, R., Lv, D., Wu, D., He, M., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13091 · Cited by 24
Neuropathic pain post-COVID-19: a case report
McWilliam, M., Samuel, M., & Alkufri, F. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-243459 · Cited by 24
Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)?
O’Donnell, J. S., & Chappell, K. J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.724654 · Cited by 24
Toll-like Receptors in Viral Encephalitis
Gern, O. L., Mulenge, F., Pavlou, A., Ghita, L., Steffen, I., Stangel, M., & Kalinke, U. (2021) · Viruses · doi:10.3390/v13102065 · Cited by 24
Clinical Artificial Intelligence Applications in Radiology
Lee, S., & Summers, R. M. (2021) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2021.07.001 · Cited by 24
Precision Postbiotics and Mental Health: the Management of Post-COVID-19 Complications
Pandey, M., Bhati, A., Priya, K. G. G. L. S., Sharma, K. K., & Singhal, B. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09875-4 · Cited by 24
Prior fluid and electrolyte imbalance is associated with COVID-19 mortality
Nahkuri, S., Becker, T., Schueller, V., Maßberg, S., & Bauer‐Mehren, A. (2021) · Communications Medicine · doi:10.1038/s43856-021-00051-x · Cited by 24
Thrombosis, cancer, and COVID-19
Brito-Dellan, N., Tsoukalas, N., & Font, C. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07098-z · Cited by 24
Agostinis, C., Toffoli, M., Spazzapan, M., Balduit, A., Zito, G., Mangogna, A., Zupin, L., Salviato, T., Maiocchi, S., Romano, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.957224 · Cited by 24
Alvarez, M., Trent, E., Gonçalves, B. D. S., Pereira, D. G., Puri, R., Frazier, N. A., Sodhi, K., & Pillai, S. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1020092 · Cited by 24
A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease
Keykavousi, K., Nourbakhsh, F., Abdollahpour, N., Fazeli, F., Sedaghat, A., Soheili, V., & Sahebkar, A. (2022) · International Journal of Analytical Chemistry · doi:10.1155/2022/9006487 · Cited by 24
Liver alterations and detection of SARS-CoV-2 RNA and proteins in COVID-19 autopsies
Pesti, A., Danics, K., Glasz, T., Várkonyi, T., Barbai, T., Reszegi, A., Kovalszky, I., Valyi-Nagy, I. T., Dobi, D., Lotz, G., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00700-6 · Cited by 24
Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers
Liu, A., Hammond, R., Donnelly, P., Kaski, J. C., & Coates, A. R. M. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13646 · Cited by 24
Ferroptosis and multi-organ complications in COVID-19: mechanisms and potential therapies
Li, Q., Chen, Z., Zhou, X., Li, G., Zhang, C., & Yang, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1187985 · Cited by 25
Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome
Moreno-Corona, N. C., López‐Ortega, O., Pérez-Martínez, C. A., Castillo, M. M., Jesús‐González, L. A. D., León‐Reyes, G., & León‐Juárez, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914822 · Cited by 24
Fontana, J. M., Alito, A., Piterà, P., Verme, F., Cattaldo, S., Cornacchia, M., Mai, S., Brunani, A., & Capodaglio, P. (2023) · Biomedicines · doi:10.3390/biomedicines11113092 · Cited by 24
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Velásquez, P. A. C., Hernández, J. C., Galeano, E., Hincapié-García, J. A., Rugeles, M. T., & Zapata, W. (2024) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s429064 · Cited by 24
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine
Prasad, K., Ahamad, S., Hema, K., Gupta, D. K., & Kumar, V. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00019 · Cited by 24
Almutlaq, M., Alamro, A. A., Alroqi, F. J., & Barhoumi, T. (2021) · CJC Open · doi:10.1016/j.cjco.2021.04.004 · Cited by 24
Study of Post-COVID-19 Syndrome in Saudi Arabia
Mahmoud, M. H., Alghamdi, F. A., Alghamdi, G. A., Alkhotani, L. A., Alrehaili, M. A. M., & Eldeeb, D. (2021) · Cureus · doi:10.7759/cureus.17787 · Cited by 24
Rethinking Remdesivir: Synthesis, Antiviral Activity and Pharmacokinetics of Oral Lipid ProdrugsPreprint
Schooley, R. T., Carlin, A. F., Beadle, J. R., Valiaeva, N., Zhang, X.-Q., Clark, A. E., McMillan, R. E., Leibel, S. L., McVicar, R. N., Xie, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.26.269159 · Cited by 24
Yantiss, R. K., Qin, L., He, B., Crawford, C. V., Seshan, S., Patel, S., Wahid, N., & Jessurun, J. (2022) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001755 · Cited by 23
Santopolo, S., Riccio, A., & Santoro, M. G. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.080 · Cited by 23
Yeates, E. O., Nahmias, J. T., Chinn, J. O., Sullivan, B. G., Stopenski, S. J., Amin, A., & Nguyen, N. T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253767 · Cited by 23
Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients
Bell, J. S., James, B., Al‐Chalabi, S., Sykes, L., Kalra, P. A., & Green, D. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02471-2 · Cited by 23
Melkumyants, A. M., Buryachkovskaya, L. I., Lomakin, N. V., Antonova, O. A., & Serebruany, V. L. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1551-9911 · Cited by 23
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis
Musiu, C., Caligola, S., Fiore, A., Lamolinara, A., Frusteri, C., Pizzo, F. D. D., Sanctis, F. D., Canè, S., Adamo, A., Hofer, F., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00866-0 · Cited by 23
Autonomic dysfunction post–acute COVID-19 infection
Desai, A. D., Boursiquot, B. C., Moore, C. J., Gopinathannair, R., Waase, M. P., Rubin, G. A., & Wan, E. Y. (2022) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2021.11.019 · Cited by 23
Self-citationZanganeh, S., Goodarzi, N., Doroudian, M., & Movahed, E. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2321 · Cited by 23
COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S)
Niess, A. M., Widmann, M., Gaidai, R., Gölz, C., Schubert, I., Castillo, K., Sachs, J. P., Bizjak, D. A., Vollrath, S., Wimbauer, F., et al. (2022) · International Journal of Public Health · doi:10.3389/ijph.2022.1604414 · Cited by 23
Gambella, A., Barreca, A., Biancone, L., Roccatello, D., Peruzzi, L., Besso, L., Licata, C., Attanasio, A., Papotti, M. G., & Cassoni, P. (2022) · Biomolecules · doi:10.3390/biom12020298 · Cited by 23
Central diabetes insipidus secondary to COVID-19 infection: a case report
Yavari, A., Sharifan, Z., Larijani, B. A., & Khah, A. M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01048-w · Cited by 23
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
Zhu, Z., Shi, J., Li, L., Wang, J., Zhao, Y., & Ma, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.870216 · Cited by 23
Oh, D., Hölzer, M., Paraskevopoulou, S., Trofimova, M., Hartkopf, F., Budt, M., Wedde, M., Richard, H., Haldemann, B., Domaszewska, T., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac399 · Cited by 23
Tong, M., Yan, X., Jiang, Y., Jin, Z., Zhu, S., Zou, L., Liu, Y., Zheng, Q., Chen, G., Gui, R. G., et al. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.033 · Cited by 23
Imaging and neuropathological findings in patients with Post COVID-19 Neurological Syndrome—A review
Okrzeja, J., Garkowski, A., Kubas, B., & Moniuszko-Malinowska, A. M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1136348 · Cited by 23
Gajula, S. N. R., Khairnar, A. S., Jock, P., Kumari, N., Pratima, K., Munjal, V., Kalan, P., & Sonti, R. (2023) · Expert Review of Proteomics · doi:10.1080/14789450.2023.2191845 · Cited by 23
Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
Wang, R., & Loscalzo, J. (2023) · Circulation Research · doi:10.1161/circresaha.122.321879 · Cited by 23
Sapna, F., Deepa, F., Sakshi, F., Sonam, F., Kiran, F., Perkash, R. S., Bendari, A., Kumar, A., Rizvi, Y., Suraksha, F., et al. (2023) · Cureus · doi:10.7759/cureus.44588 · Cited by 23
Sideratou, C.-M., & Papaneophytou, C. P. (2023) · Infectious Disease Reports · doi:10.3390/idr15060072 · Cited by 23
Strategies and Advances in Combating COVID-19 in China
Liu, W. Y., Guan, W., & Zhong, N. (2020) · Engineering · doi:10.1016/j.eng.2020.10.003 · Cited by 23
Carducci, F. I. C., Ioris, M. A. D., Agrati, C., Carsetti, R., Perrotta, D., D’Argenio, P., Benedetti, F. D., Notari, S., Rossi, P., & Campana, A. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.576912 · Cited by 23
Memish, Z. A., Faqihi, F. A., Alharthy, A. M., Alqahtani, S. A., & Karakitsos, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106273 · Cited by 23
Gorman, S., & Weller, R. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.616527 · Cited by 23
Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection
Bielarz, V., Willemart, K., Avalosse, N., Swert, K. D., Lotfi, R., Lejeune, N., Poulain, F., Ninane, N., Gilloteaux, J., Gillet, N. A., et al. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147344 · Cited by 23
COVID-19 in trauma: a propensity-matched analysis of COVID and non-COVID trauma patients
Yeates, E. O., Grigorian, A., Schellenberg, M. A., Owattanapanich, N., Barmparas, G., Margulies, D. R., Juillard, C. J., Garber, K. D., Cryer, H., Tillou, A., et al. (2021) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-021-01699-9 · Cited by 23
Koutsiaris, A. G., Riri, K., Boutlas, S., Panagiotou, T. N., Kotoula, M. G., Daniil, Z. D., & Tsironi, E. E. (2022) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-221554 · Cited by 23
de Vries, R., Vigeveno, R. M., Mulder, S., Farzan, N., Vintges, D. R., Goeman, J. J., Bruisten, S. M., van den Corput, B., Geelhoed, J. J. M., Visser, L. G., et al. (2021) · medRxiv · doi:10.1101/2021.02.14.21251712 · Cited by 23
Alu retrotransposons and COVID-19 susceptibility and morbidity
Li, M., Schifanella, L., & Larsen, P. A. (2021) · Human Genomics · doi:10.1186/s40246-020-00299-9 · Cited by 22
Inter-relação entre COVID-19 e diabetes mellitus: uma revisão sistemática
Marinho, F. P., de Loyola, I. S., Monteiro, I. D. O. F., Castro, T. M., Carvalho, M. D. G. D. S., Garcia, J. A. D., Silvério, A. C. P., & Santos, G. B. (2021) · Research Society and Development · doi:10.33448/rsd-v10i2.12191 · Cited by 22
Bergamo and Covid-19: How the Dark Can Turn to Light
Perico, N., FAGIUOLI, S., Marco, F. D., Laghi, A., Cosentini, R., Rizzo, M., Gianatti, A., Rambaldi, A., Ruggenenti, P. L., Vecchia, C. L., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.609440 · Cited by 22
Cyclic 68 Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2
Parker, M. F. L., Blecha, J. E., Rosenberg, O. S., Ohliger, M. A., Flavell, R. R., & Wilson, D. M. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.261768 · Cited by 23
Metadata
- Authors
- Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., Freedberg, D. E., Kirtane, A. J., Parikh, S. A., Maurer, M. S., Nordvig, A. S., Accili, D., Bathon, J. M., Mohan, S., Bauer, K. A., Leon, M. B., Krumholz, H. M., Uriel, N., Mehra, M. R., Elkind, M. S. V., Stone, G. W., Schwartz, A., Ho, D. D., Bilezikian, J. P., & Landry, D. W.
- Affiliations
- Yale New Haven Hospital (US)
- Columbia University Irving Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- Mayo Clinic (US)
- Icahn School of Medicine at Mount Sinai (US)
- Cardiovascular Research Foundation (US)
- NewYork–Presbyterian Hospital (US)
- Brigham and Women's Hospital (US)
- Aaron Diamond AIDS Research Center (US)
- Corresponding author
- Landry, Donald W.
- ORCID
- Gupta, Aakriti
- Madhavan, Mahesh V.
- Sehgal, Kartik
- Mahajan, Shiwani
- Sehrawat, Tejasav S.
- Bikdeli, Behnood
- Ahluwalia, Neha
- Ausiello, John C.
- Wan, Elaine Y.
- Freedberg, Daniel E.
- Kirtane, Ajay J.
- Parikh, Sahil A.
- Maurer, Mathew S.
- Nordvig, Anna S.
- Accili, Domenico
- Bathon, Joan M.
- Mohan, Sumit
- Bauer, Kenneth A.
- Leon, Martin B.
- Krumholz, Harlan M.
- Uriel, Nir
- Mehra, Mandeep R.
- Elkind, Mitchell S. V.
- Stone, Gregg W.
- Schwartz, Allan
- Ho, David D.
- Bilezikian, John P.
- Landry, Donald W.
- Venue
- Nature Medicine
- Published
- 2020-07
- Volume
- 26
- Issue
- 7
- Pages
- 1017-1032
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC11972613
- OpenAlex
- W3040801404
- Cited by
- 3,185
- References
- 261
- Citations by year
- 2026: 125 · 2025: 182 · 2024: 333 · 2023: 558 · 2022: 751 · 2021: 965 · 2020: 261
- FWCI
- 29.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | National Institutes of Health (T32 - HL007854, K23- DK111847)
- U.S. Department of Defense (PR-181960)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (5T32 - NS007153)
- U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 - AR050026, U01- AR068043)
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 - MD014161, U01- DK116066)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K08-HL122526, R01 - HL152236, R03 - HL146881)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, extrapulmonary manifestations, thrombotic complications, cardiac dysfunction, cardiac arrhythmias, acute coronary syndrome, acute kidney injury, gastrointestinal symptoms, hepatocyte injury, hyperglycemia, ketosis, neurological complications, ocular symptoms, skin complications, ACE2 receptor, thromboinflammation, endothelial injury, immune dysregulation
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Endothelium, Vascular, Humans, Inflammation, Organ Specificity, Pneumonia, Viral, Renin-Angiotensin System, Thrombosis, Coronavirus Infections, Disease Progression, Virus Internalization, Adaptive Immunity, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
